391 related articles for article (PubMed ID: 33240092)
1. Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019.
Nagarkatti P; Miranda K; Nagarkatti M
Front Pharmacol; 2020; 11():589438. PubMed ID: 33240092
[TBL] [Abstract][Full Text] [Related]
2. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
[TBL] [Abstract][Full Text] [Related]
3. Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.
Mehta Y; Dixit SB; Zirpe KG; Ansari AS
Indian J Crit Care Med; 2020 Jun; 24(6):429-434. PubMed ID: 32863636
[TBL] [Abstract][Full Text] [Related]
4. Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome?
Falcone C; Caracciolo M; Correale P; Macheda S; Vadalà EG; La Scala S; Tescione M; Danieli R; Ferrarelli A; Tarsitano MG; Romano L; De Lorenzo A
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32967358
[TBL] [Abstract][Full Text] [Related]
5. Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches.
Mannino F; Bitto A; Irrera N
Front Pharmacol; 2020; 11():592169. PubMed ID: 33633566
[TBL] [Abstract][Full Text] [Related]
6. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.
Desjarlais M; Wirth M; Lahaie I; Ruknudin P; Hardy P; Rivard A; Chemtob S
Front Pharmacol; 2020; 11():602999. PubMed ID: 33362557
[TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm.
Morgulchik N; Athanasopoulou F; Chu E; Lam Y; Kamaly N
Interface Focus; 2022 Feb; 12(1):20210006. PubMed ID: 34956607
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA.
Khodadadi H; Salles ÉL; Jarrahi A; Chibane F; Costigliola V; Yu JC; Vaibhav K; Hess DC; Dhandapani KM; Baban B
Cannabis Cannabinoid Res; 2020; 5(3):197-201. PubMed ID: 32923657
[No Abstract] [Full Text] [Related]
9. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
Yokota S; Miyamae T; Kuroiwa Y; Nishioka K
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671159
[TBL] [Abstract][Full Text] [Related]
10. May mesenchymal stem cell transplantation be a solution for COVID-19 induced cytokine storm?
Sütlüoğlu H; Özdemir Ö
World J Transplant; 2021 Aug; 11(8):344-355. PubMed ID: 34447671
[TBL] [Abstract][Full Text] [Related]
11. Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients.
Cala-García JD; Sierra-Bretón JD; Cavelier-Baiz JE; Faccini-Martínez ÁA; Pérez-Díaz CE
Immunotherapy; 2020 Oct; 12(15):1127-1132. PubMed ID: 32664810
[No Abstract] [Full Text] [Related]
12. Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019.
Bifulco M; Fiore D; Piscopo C; Gazzerro P; Proto MC
Front Pharmacol; 2021; 12():631646. PubMed ID: 33912048
[No Abstract] [Full Text] [Related]
13. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.
Arjmand B; Alavi-Moghadam S; Parhizkar Roudsari P; Rezaei-Tavirani M; Rahim F; Gilany K; Mohamadi-Jahani F; Adibi H; Larijani B
Front Cell Dev Biol; 2021; 9():675310. PubMed ID: 34195193
[TBL] [Abstract][Full Text] [Related]
14. The Imperfect Cytokine Storm: Severe COVID-19 With ARDS in a Patient on Durable LVAD Support.
Chau VQ; Oliveros E; Mahmood K; Singhvi A; Lala A; Moss N; Gidwani U; Mancini DM; Pinney SP; Parikh A
JACC Case Rep; 2020 Jul; 2(9):1315-1320. PubMed ID: 32292915
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome.
Lin F; Ichim TE; Pingle S; Jones LD; Kesari S; Ashili S
World J Stem Cells; 2020 Oct; 12(10):1067-1079. PubMed ID: 33178392
[TBL] [Abstract][Full Text] [Related]
16. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
[TBL] [Abstract][Full Text] [Related]
17. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
18. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids as Emergent Therapy Against COVID-19.
McGrail J; Martín-Banderas L; Durán-Lobato M
Cannabis Cannabinoid Res; 2022 Oct; 7(5):582-590. PubMed ID: 35512732
[TBL] [Abstract][Full Text] [Related]
20. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
Can A; Coskun H
Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
